Biotechnology Letters

, Volume 30, Issue 2, pp 205–214

Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus

  • Cheng-Wen Lin
  • Kuang-Ting Liu
  • Hong-Da Huang
  • Wei-June Chen
Original Research Paper

DOI: 10.1007/s10529-007-9529-9

Cite this article as:
Lin, CW., Liu, KT., Huang, HD. et al. Biotechnol Lett (2008) 30: 205. doi:10.1007/s10529-007-9529-9

Abstract

Immunogenicity and protective efficacy of recombinant Japanese encephalitis virus (JEV) NS1 proteins generated using DNA vaccines and recombinant viruses have been demonstrated to induce protection in mice against a challenge of JEV at a lethal dose. The West Nile virus NS1 region expressed in E. coli is recognized by these protective monoclonal antibodies and, in this study, we compare immunogenicity and protective immunity of the E. coli-synthesized NS1 protein with another protective immunogen, the envelope domain III (ED3). Pre-challenge, detectable titers of JEV-specific neutralizing antibody were detected in the immunized mice with E. coli-synthesized ED3 protein (PRNT50 = 1:28) and the attenuated JEV strain T1P1 (PRNT50 = 1:53), but neutralizing antibodies were undetectable in the immunized mice with E. coli-synthesized NS1 protein (PRNT50 < 1:10). However, the survival rate of the NS1-immunized mice against the JEV challenge was 87.5% (7/8), showing significantly higher levels of protection than the ED3-immunized mice, 62.5% (5/8) (P = 0.041). In addition, E. coli-synthesized NS1 protein induced a significant increase of anti-NS1 IgG1 antibodies, resulting in an ELISA titer of 100,1000 in the immunized sera before lethal JEV challenge. Surviving mice challenged with the virulent JEV strain Beijing-1 showed a ten-fold or greater rise in IgG1 and IgG2b titers of anti-NS1 antibodies, implying that the Th2 cell activation might be predominantly responsible for antibody responses and mice protection.

Keywords

Envelope Immunogenicity Japanese encephalitis virus NS1 proteins Viral proteins 

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Cheng-Wen Lin
    • 1
    • 2
  • Kuang-Ting Liu
    • 1
  • Hong-Da Huang
    • 1
  • Wei-June Chen
    • 3
  1. 1.Department of Medical Laboratory Science and BiotechnologyChina Medical UniversityTaichungTaiwan, ROC
  2. 2.Clinical Virology Laboratory, Department of Laboratory MedicineChina Medical University HospitalTaichungTaiwan, ROC
  3. 3.Department of Public Health and Parasitology, College of MedicineChang Gung UniversityKwei-San, Tao-YuanTaiwan, ROC

Personalised recommendations